Related Experiment Video
Updated: Jul 3, 2026
07:39
Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
The placenta is simply a neuroendocrine parasite
1School of Biological Sciences, University of Reading, Reading, UK. p.j.lowry@reading.ac.uk
Journal of Neuroendocrinology
|July 8, 2008
Summary
Researchers investigated the neuroendocrinology of pre-eclampsia, a dangerous pregnancy condition. Early observations suggest a specific placental factor, modified by phosphocholine, may cause pre-eclampsia symptoms by compensating for poor placental implantation.
Area of Science:
- Neuroendocrinology
- Obstetrics
- Immunology
Background:
- Pre-eclampsia is a severe pregnancy complication impacting maternal and fetal health.
- Understanding the underlying molecular mechanisms of pre-eclampsia is crucial for effective management.
- Early research focused on placental factors influencing pregnancy outcomes.
Purpose of the Study:
- To document early scientific observations driving neuroendocrinological research into pre-eclampsia.
- To explore the role of specific placental factors in the development of pre-eclampsia symptoms.
- To identify the elusive placental factor implicated in pre-eclampsia.
Main Methods:
- Tracing the neuroendocrinological interest from melanotrophin activity to tachykinin modification.
- Investigating corticotrophin-releasing factor and its binding protein.
- Analyzing placental modifications, including phosphocholine post-translational addition.
Main Results:
- Identified a link between placental melanotrophin activity and neuroendocrinology.
- Examined the role of corticotrophin-releasing factor and its binding protein.
- Discovered a tachykinin modified by phosphocholine in the placenta, a mechanism typically used by parasites to evade immune responses.
Conclusions:
- The research provides insights into the neuroendocrinology of pre-eclampsia.
- A specific placental factor, modified by phosphocholine, is proposed as a cause of pre-eclampsia symptoms.
- This factor may attempt to compensate for poor placental implantation, leading to maternal symptoms.
Related Concept Videos
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:14Fetal Circulation
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
01:30Neurulation
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
01:25Physiological Barriers
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...